International consensus panel on the treatment of primary breast cancer-Reference-Cited by-同舟云学术

International consensus panel on the treatment of primary breast cancer

Published:1995-10 Issue:11 Volume:31 Page:1754-1759
ISSN:0959-8049
Container-title:European Journal of Cancer
language:en
Short-container-title:European Journal of Cancer

Author:

Goldhirsch A.,Wood W.C.,Senn H.-J.,Glick J.H.,Gelber R.D.

Publisher

Elsevier BV

Subject

Cancer Research,Oncology

Reference16 articles.

1. Meeting highlights: adjuvant therapy for primary breast cancer;Glick;J Natl Cancer Inst,1992

2. Adjuvant therapy of primary breast cancer;Glick;Ann Oncol,1992

3. Systemic treatment for early breast cancer by hormonal, cytotoxic, or immune therapy: 133 randomised trials involving 31000 recurrences and 24000 deaths among 75000 women;Lancet,1992

4. Systemic treatment for early breast cancer by hormonal, cytotoxic, or immune therapy: 133 randomised trials involving 31000 recurrences and 24000 deaths among 75000 women;Lancet,1992

5. Lumpectomy compared with lumpectomy and radiation therapy for the treatment of intraductal breast cancer;Fisher;N Engl J Med,1993

Cited by 42 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Clinicopathologic characteristics and prognosis for male breast cancer compared to female breast cancer;Scientific Reports;2022-01-07

2. Long-term prognosis of young breast cancer patients (≤40 years) who did not receive adjuvant systemic treatment: protocol for the PARADIGM initiative cohort study;BMJ Open;2017-11

3. The adherence paradox: guideline deviations contribute to the increased 5-year survival of breast cancer patients;BMC Cancer;2015-10-19

4. The effects of alpha-lipoic acid on breast of female albino rats exposed to malathion: Histopathological and immunohistochemical study;Pathology - Research and Practice;2015-06

5. miR-29b is an indicator of prognosis in breast cancer patients;Molecular and Clinical Oncology;2015-05-12